Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03660618 · ClinicalTrials.gov registry record · NA
LSFG-SKIN, Laser Speckle Flowgraphy
A NA study, sponsored by Randy Kardon.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03660618: Clinical Trial NA study, sponsored by Randy Kardon.
NCT03660618 is a NA study that was terminated before completion, run by Randy Kardon. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03660618, a NA study, was terminated before completion, sponsored by Randy Kardon.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.
Primary Outcome
Imaging blood flow in the tissue is of major importance in the clinical environment
Interventions
- DEVICE laser speckle flowgraphy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-05-23 |
| Est. Completion | 2019-03-02 |
| Phase | NA |
Why NCT03660618 stopped before completion
NCT03660618 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which laser speckle flowgraphy is the first listed.
NCT03660618 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03660618 about?
NCT03660618 is a clinical study titled "LSFG-SKIN, Laser Speckle Flowgraphy". The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.
What is the current status of trial NCT03660618?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-05-23. Estimated completion is 2019-03-02.
What interventions are being tested in trial NCT03660618?
The interventions under investigation include: laser speckle flowgraphy (DEVICE).
Who is sponsoring clinical trial NCT03660618?
This trial is sponsored by Randy Kardon, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03660618's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI